Cargando…
A novel CaSR mutation presenting as a severe case of neonatal familial hypocalciuric hypercalcemia
BACKGROUND: Familial Hypocalciuric Hypercalcemia (FHH) is a generally benign disorder caused by heterozygous inactivating mutations in the Calcium-Sensing Receptor (CaSR) gene resulting in altered calcium metabolism. OBJECTIVE: We report a case of unusually severe neonatal FHH due to a novel CaSR ge...
Autores principales: | Tonyushkina, Ksenia N, O’Connor, Stephen, Dunbar, Nancy S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465174/ https://www.ncbi.nlm.nih.gov/pubmed/22620673 http://dx.doi.org/10.1186/1687-9856-2012-13 |
Ejemplares similares
-
Familial hypocalciuric hypercalcemia caused by homozygous CaSR gene mutation: A case report of a family
por: Wang, Feifei, et al.
Publicado: (2020) -
SAT-350 A Tale of Two Mutations: Familial Hypocalciuric Hypercalcemia Caused by a Novel CaSR Start Codon Mutation Found in the Setting of a CaSR Hypercalciuric Variant
por: Bandaru, Sindhura, et al.
Publicado: (2020) -
Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies
por: Makita, Noriko, et al.
Publicado: (2022) -
Identification of a novel large CASR deletion in a patient with familial hypocalciuric hypercalcemia
por: García-Castaño, Alejandro, et al.
Publicado: (2018) -
A Novel Missense CASR Gene Sequence Variation Resulting in Familial Hypocalciuric Hypercalcemia
por: Bletsis, Panagiotis, et al.
Publicado: (2022)